E-vaporating benefits of e-vaping
Eur Heart J
.
2020 Jul 7;41(26):2484-2486.
doi: 10.1093/eurheartj/ehz875.
Authors
Mateusz Siedlinski
1
2
,
David G Harrison
3
,
Tomasz J Guzik
1
2
Affiliations
1
Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK.
2
Department of Medicine, Jagiellonian University Medical College, Krakow, Poland.
3
Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University, Nashville, TN, USA.
PMID:
31803927
PMCID:
PMC7340352
DOI:
10.1093/eurheartj/ehz875
No abstract available
Publication types
Editorial
Comment
MeSH terms
Brain
E-Cigarette Vapor*
Electronic Nicotine Delivery Systems*
Humans
NADPH Oxidases
Oxidative Stress
Vaping*
Substances
E-Cigarette Vapor
NADPH Oxidases
Grants and funding
P01 HL129941/HL/NHLBI NIH HHS/United States
R35 HL140016/HL/NHLBI NIH HHS/United States